Market open

scPharmaceuticals/$SCPH

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About scPharmaceuticals

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

Ticker

$SCPH
Trading on

Industry

Pharmaceuticals

Employees

136

SCPH Metrics

BasicAdvanced
$171M
Market cap
-
P/E ratio
-$1.96
EPS
0.10
Beta
-
Dividend rate
$171M
0.1
$6.60
$3.08
636K
8.08
6.672
170.198
170.95
-7.79%
-34.44%
-200.65%
4.612
5.57
5.57
-1.979
303.87%
43.06%
23.38%

What the Analysts think about SCPH

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for scPharmaceuticals stock.

SCPH Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

SCPH Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $SCPH

$

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events

FAQs

What’s the current market cap for scPharmaceuticals stock?

scPharmaceuticals (SCPH) has a market cap of $171M as of December 30, 2024.

What is the P/E ratio for scPharmaceuticals stock?

The price to earnings (P/E) ratio for scPharmaceuticals (SCPH) stock is 0 as of December 30, 2024.

Does scPharmaceuticals stock pay dividends?

No, scPharmaceuticals (SCPH) stock does not pay dividends to its shareholders as of December 30, 2024.

When is the next scPharmaceuticals dividend payment date?

scPharmaceuticals (SCPH) stock does not pay dividends to its shareholders.

What is the beta indicator for scPharmaceuticals?

scPharmaceuticals (SCPH) has a beta rating of 0.1. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.